wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36355098-FBC02A5F-B99C-4908-A324-BDBEE966C2B0
Q36355098-FBC02A5F-B99C-4908-A324-BDBEE966C2B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36355098-FBC02A5F-B99C-4908-A324-BDBEE966C2B0
Managing chronic myeloid leukemia patients intolerant to tyrosine kinase inhibitor therapy.
P2860
Q36355098-FBC02A5F-B99C-4908-A324-BDBEE966C2B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36355098-FBC02A5F-B99C-4908-A324-BDBEE966C2B0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ee6fa58daf42e1d06bcd280815ad378f45f76d6
P2860
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure